Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

被引：0
|
作者：
Lan Mu
Ke Ding
Ranran Tu
Wei Yang
机构：
[1] Central South University,Department of Thyroid Surgery, The Second Xiangya Hospital
[2] Central South University,Department of Urology, Xiangya Hospital
[3] Central South University,Department of Neurology, The Second Xiangya Hospital
[4] Central South University,Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital
来源：
Journal of Translational Medicine | / 19卷
关键词：
Lung adenocarcinoma; Immune infiltration; LncRNA; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence
    Saji, Hisashi
    Tsuboi, Masahiro
    Shimada, Yoshihisa
    Kato, Yasufumi
    Hamanaka, Wakako
    Kudo, Yujin
    Yoshida, Koichi
    Matsubayashi, Jun
    Usuda, Jitsuo
    Ohira, Tatsuo
    Ikeda, Norihiko
    ONCOLOGY REPORTS, 2013, 29 (05) : 1902 - 1906
  • [22] Identification of early-stage lung adenocarcinoma prognostic signatures based on statistical modeling
    Wu, Chunxiao
    Zhang, Donglei
    CANCER BIOMARKERS, 2017, 18 (02) : 117 - 123
  • [23] Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
    Huan, Sheng
    Chen, Miao
    Sun, Sumin
    Zhong, Yanling
    Chen, Yu
    Ji, Yihao
    Yin, Guoping
    FRONTIERS IN GENETICS, 2022, 13
  • [24] Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma
    Li, Liang
    Yu, Xue
    Ma, Guanqiang
    Ji, Zhiqi
    Bao, Shihao
    He, Xiaopeng
    Song, Liang
    Yu, Yang
    Shi, Mo
    Liu, Xiangyan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 9007 - 9022
  • [25] Rapid Identification of Micropapillary or Solid Component for Early-Stage Lung Adenocarcinoma
    Zhao, Z.
    Lau, R.
    Mok, T.
    Chen, G.
    Underwood, M.
    Ng, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2349 - S2349
  • [26] A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma
    Zhao, Yanding
    Varn, Frederick S.
    Cai, Guoshuai
    Xiao, Feifei
    Amos, Christopher I.
    Cheng, Chao
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (01) : 86 - 95
  • [27] Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
    Kui Cao
    Mingdong Liu
    Keru Ma
    Xiangyu Jiang
    Jianqun Ma
    Jinhong Zhu
    Cancer Immunology, Immunotherapy, 2022, 71 : 1295 - 1311
  • [28] Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
    Cao, Kui
    Liu, Mingdong
    Ma, Keru
    Jiang, Xiangyu
    Ma, Jianqun
    Zhu, Jinhong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1295 - 1311
  • [29] Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma
    Tian, Long
    Wang, Yan
    Tian, Jie
    Song, Wenpeng
    Li, Lu
    Che, Guowei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [30] Identification of a Risk Signature and Immune Cell Infiltration Based on Extracellular Matrix-Related lncRNAs in Lung Adenocarcinoma
    Zhang, Moyuan
    Cen, Tianqi
    Huang, Shaohui
    Wang, Chaoyang
    Wu, Xuan
    Zhao, Xingru
    Xu, Zhiwei
    Zhang, Xiaoju
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2025, 35 (01):
12345